---
title: "Haemonetics completes acquisition of OpSens"
date: "2023-12-12T14:15:31.000Z"
publishedDate: "12 décembre 2023"
summary: "Haemonetics Corporation has completed its acquisition of OpSens, the company announced in a press release today. Haemonetics acquired all outstanding shares of OpSens for CAD$2.90 per share in the all-cash transaction, representing a fully diluted equity value of approximately US$255 million at the current exchange rate."
importance: ""
sourceUrl: "https://cardiovascularnews.com/haemonetics-completes-acquisition-of-opsens/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-12-12-haemonetics-completes-acquisition-of-opsens"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/Opsens-haemonetics-logo-1.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/haemonetics-completes-acquisition-of-opsens/"
---

![Haemonetics completes acquisition of OpSens](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/12/Opsens-haemonetics-logo-1.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/haemonetics-completes-acquisition-of-opsens/*

## L’essentiel

Haemonetics Corporation has completed its acquisition of OpSens, the company announced in a press release today. Haemonetics acquired all outstanding shares of OpSens for CAD$2.90 per share in the all-cash transaction, representing a fully diluted equity value of approximately US$255 million at the current exchange rate.

## Lien source

https://cardiovascularnews.com/haemonetics-completes-acquisition-of-opsens/
